The preoperative kinetics of prostate-specific antigen as a predict of relapse-free survival after radical prostatectomy

The preoperative kinetics of prostate-specific antigen as a predict of relapse-free survival after radical prostatectomy

Show other versions (1)

<p><strong>Objectivе.</strong> The purpose of the study – to estimate the prognostic value of preoperative prostate-specific antigen (PSA) doubling time (PSADT) in patients with prostate cancer (PCa) after radical prostatectomy (RP).</p><p><strong>Materials and Me...

Full description

Bibliographic Details
Main Authors:	O. A. Bogomolov, M. I. Shkolnik, G. M. Zharinov
Format:	Article
Language:	Russian
Published:	ABV-press 2014-12-01
Series:	Onkourologiâ
Subjects:	prostate cancer preoperative prostate-specific antigen doubling time
Online Access:	http://oncourology.abvpress.ru/index.php/oncur/article/view/396

Similar Items

The preoperative kinetics of prostate-specific antigen as a predict of relapse-free survival after radical prostatectomy
by: O. A. Bogomolov, et al.
Published: (2014-12-01)

THE PRETREATMENT PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME: CLINICAL AND PROGNOSTIC VALUES IN PATIENTS WITH PROSTATE CANCER
by: G. M. Zharinov, et al.
Published: (2014-07-01)

THE PRETREATMENT PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME: CLINICAL AND PROGNOSTIC VALUES IN PATIENTS WITH PROSTATE CANCER
by: G. M. Zharinov, et al.
Published: (2014-07-01)

Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy
by: Р. V. Bulychkin, et al.
Published: (2019-07-01)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
by: Marcos F. Dall'oglio, et al.
Published: (2005-06-01)

Increased Preoperative Plasma Level of Microbial 16S rDNA Translocation Is Associated With Relapse After Prostatectomy in Prostate Cancer Patients
by: Tongwen Ou, et al.
Published: (2020-01-01)

Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
by: Philipp Mandel, et al.
Published: (2021-07-01)

The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy
by: Antonio B. Porcaro, et al.
Published: (2016-03-01)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
by: Nelson Gianni de Lima, et al.
Published: (2013-06-01)

Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
by: Sinan Avci, et al.
Published: (2020-04-01)

Salvage conformal radiotherapy for biochemical recurrent prostate cancer after radical prostatectomy
by: Carlos R. Monti, et al.
Published: (2006-08-01)

Prostate-specific antigen density as a parameter for the prediction of positive lymph nodes at radical prostatectomy
by: Theocharis Yiakoumos, et al.
Published: (2015-01-01)

Evaluation of heterogeneous factors of low-grade prostate cancer in patients before and after radical prostatectomy
by: E. I. Veliev, et al.
Published: (2020-11-01)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
by: Yadong Guo, et al.
Published: (2019-07-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

Specificity and sensitivity of preoperative total serum prostate specific antigen in diagnosis most common histopathological change of prostate
by: Mijović Milica, et al.
Published: (2017-01-01)

Biochemical recurrence after radical prostatectomy: what does it mean?
by: Rafael Tourinho-Barbosa, et al.

Prostate-specific antigen and prostate-specific antigen kinetics in predicting 18F-sodium fluoride positron emission tomography-computed tomography positivity for first bone metastases in patients with biochemical recurrence after radical prostatectomy
by: James Yoon, et al.
Published: (2017-01-01)

Moving ahead of prostate-specific antigen
by: Banyameen Mohamad Iqbal, et al.
Published: (2016-01-01)

The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer
by: Bai X, et al.
Published: (2020-08-01)

Does index tumor predominant location influence prognostic factors in radical prostatectomies?
by: Athanase Billis, et al.

FREE/TOTAL PROSTATE SPECIFIC ANTIGEN RATIO AS PREDICTOR FOR PROSTATE CARCINOMA
by: Sajjad Ahmad, et al.
Published: (2017-08-01)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020-05-01)

ADJUVANT RADIOTHERAPY AFTER RADICAL PROSTATECTOMY
by: O. В. Karyakin
Published: (2014-07-01)

ADJUVANT RADIOTHERAPY AFTER RADICAL PROSTATECTOMY
by: O. В. Karyakin
Published: (2014-07-01)

Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame?
by: Adnan Simsir, et al.
Published: (2011-06-01)

The presence of prostate-specific antigen checked more than 1 year before diagnostic biopsy is an independent prognostic factor in patients undergoing radical prostatectomy
by: Sung Gon Park, et al.
Published: (2021-07-01)

The Clinical Impact of Unilateral Versus Bilateral Invasion Into the Seminal Vesicle in Patients With Prostate Cancer Undergoing Radical Prostatectomy
by: Gurung, P.M.S, et al.
Published: (2022)

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml−1
by: Rui Chen, et al.
Published: (2015-01-01)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
by: Jeremy YC Teoh, et al.
Published: (2017-01-01)

Socioeconomic status is an independent predictor of biochemical recurrence among patients with prostate cancer who undergo radical prostatectomy
by: Victor Srougi, et al.
Published: (2011-08-01)

Early Dutasteride Monotherapy in Patients With Elevated Serum Prostate-Specific Antigen Levels Following Robot-Assisted Radical Prostatectomy
by: Chin-Heng Lu, et al.
Published: (2019-08-01)

Analysis of the Correlationship between Prostate Specific Antigen Related Variables and Risk Factor in Patients with Prostate Carcinoma
by: Daoyuan Wang, et al.
Published: (2015-01-01)

Benign prostatic hyperplasia and prostate-specific antigen
by: Pejčić Tomislav, et al.
Published: (2015-01-01)

Analysis of risk factors of involvement of seminal vesicles in patients with prostate cancer undergoing radical prostatectomy
by: Marcos F. Dall'Oglio, et al.
Published: (2004-12-01)

The results of transrectal prostate biopsy in patients with low levels of prostate specific antigen
by: Ahmet Ali Sancaktutar, et al.
Published: (2012-06-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

PROSTATE SPECIFIC ANTIGEN LEVEL FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE
by: Johannes Aritonang, et al.
Published: (2020-01-01)

Prostate Specific Antigen (PSA): The Historical Perspective
by: T. Ming Chu
Published: (2020-12-01)

Prostate specific antigen levels following transurethral resection of the prostate
by: Roberto C. Fonseca, et al.
Published: (2008-02-01)

Cannot write session to /tmp/vufind_sessions/sess_9gseq819ifcv9n7cqjn89t63hd